Looking for a rising tide

For those waiting for some event to re-establish the biotechnology model and create a rising tide of investor interest in the sector, last week's boffo Wall Street response to Biogen's multiple sclerosis announcement must have raised hopes.

As the graphic above shows, however, BGEN's big splash didn't immediately raise the water level in the bathtub for the rest of the sector.